What does PHARMACIE LOUDIERE do?

PHARMACIE LOUDIERE is a pharmacy in Namur. Private Limited, started on 17 July 2013, 1 establishment.

What is the address of PHARMACIE LOUDIERE?

The registered office of PHARMACIE LOUDIERE is located at Rue des Mésanges(JB) 13, 5100 Namur.

Is PHARMACIE LOUDIERE still active?

Yes. According to the CBE (30 September 2026) PHARMACIE LOUDIERE is active, legal situation “Normale toestand”, started on 17 July 2013.

Is PHARMACIE LOUDIERE registered on Peppol?

Yes, PHARMACIE LOUDIERE is registered on the Peppol network with ID 0208:0536753854.

What is the enterprise number of PHARMACIE LOUDIERE?

The enterprise number of PHARMACIE LOUDIERE is BE0536753854.

When was PHARMACIE LOUDIERE founded?

PHARMACIE LOUDIERE was founded on 17 July 2013.

Who are the directors of PHARMACIE LOUDIERE?

According to the 2025 annual accounts, the directors of PHARMACIE LOUDIERE are: ARTUS LOUDIERE.

Is PHARMACIE LOUDIERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 July 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE LOUDIERE make in 2025?

PHARMACIE LOUDIERE posted a profit after taxes of € 22,797 in financial year 2025.

What is the revenue of PHARMACIE LOUDIERE?

As a small company, PHARMACIE LOUDIERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 35,524.

PHARMACIE LOUDIERE (Private Limited) - Namur

Dossier PHARMACIE LOUDIERE, printed on 30 September 2026 from databakkes.be/en/0536753854/pharmacie-loudiere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE LOUDIERE from Namur, company number BE0536753854, closed financial year 2025 with a result of € 22,797 after tax. For that financial year PHARMACIE LOUDIERE recorded a gross margin of € 35,524 and equity of € 199,513. Compared with financial year 2024, the result moved from € 23,483 to € 22,797. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Growing

€ 199,513

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 22,797

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,729

▼ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 16,842 paid out

74 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,000

▼ 20% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,049

▲ 27% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,124

▼ 49% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 24,949 Gross margin 2022: € 24,949 First fiscal year in the series	€ 31,393 Gross margin 2023: € 31,393 ▲ 26% vs 2022 (€ 24,949) Favourable step	€ 38,234 Gross margin 2024: € 38,234 ▲ 22% vs 2023 (€ 31,393) Favourable step	€ 35,524 Gross margin 2025: € 35,524 ▼ 7% vs 2024 (€ 38,234) Unfavourable step	▼ 7%
Profit after taxes	€ 15,879 Profit after taxes 2022: € 15,879 First fiscal year in the series	€ 20,432 Profit after taxes 2023: € 20,432 ▲ 29% vs 2022 (€ 15,879) Favourable step	€ 23,483 Profit after taxes 2024: € 23,483 ▲ 15% vs 2023 (€ 20,432) Favourable step	€ 22,797 Profit after taxes 2025: € 22,797 ▼ 3% vs 2024 (€ 23,483) Unfavourable step	▼ 3%
Equity	€ 172,642 Equity 2022: € 172,642 First fiscal year in the series	€ 193,075 Equity 2023: € 193,075 ▲ 12% vs 2022 (€ 172,642) Favourable step	€ 193,558 Equity 2024: € 193,558 Unchanged (€ 193,075) Favourable step	€ 199,513 Equity 2025: € 199,513 ▲ 3% vs 2024 (€ 193,558) Favourable step	▲ 3%
Total debts	€ 46,509 Total debts 2022: € 46,509 First fiscal year in the series	€ 26,114 Total debts 2023: € 26,114 ▼ 44% vs 2022 (€ 46,509) Favourable step	€ 18,736 Total debts 2024: € 18,736 ▼ 28% vs 2023 (€ 26,114) Favourable step	€ 11,173 Total debts 2025: € 11,173 ▼ 40% vs 2024 (€ 18,736) Favourable step	▼ 40%
Cash	€ 5,437 Cash 2022: € 5,437 First fiscal year in the series	€ 6,031 Cash 2023: € 6,031 ▲ 11% vs 2022 (€ 5,437) Favourable step	€ 6,074 Cash 2024: € 6,074 ▲ 1% vs 2023 (€ 6,031) Favourable step	€ 3,729 Cash 2025: € 3,729 ▼ 39% vs 2024 (€ 6,074) Unfavourable step	▼ 39%
Retained profit	€ 154,042 Retained profit 2022: € 154,042 First fiscal year in the series	€ 174,475 Retained profit 2023: € 174,475 ▲ 13% vs 2022 (€ 154,042) Favourable step	€ 174,958 Retained profit 2024: € 174,958 Unchanged (€ 174,475) Favourable step	€ 180,913 Retained profit 2025: € 180,913 ▲ 3% vs 2024 (€ 174,958) Favourable step	▲ 3%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 23,000 Dividend 2024: € 23,000 Unchanged (€ 0) Unchanged	€ 16,842 Dividend 2025: € 16,842 ▼ 27% vs 2024 (€ 23,000) Unchanged	▼ 27%
Bank debt	€ 14,286 Bank debt 2022: € 14,286 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 14,286) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 219,151 Balance sheet total 2022: € 219,151 First fiscal year in the series	€ 219,188 Balance sheet total 2023: € 219,188 Unchanged (€ 219,151) Unchanged	€ 212,294 Balance sheet total 2024: € 212,294 ▼ 3% vs 2023 (€ 219,188) Unchanged	€ 210,687 Balance sheet total 2025: € 210,687 ▼ 1% vs 2024 (€ 212,294) Unchanged	▼ 1%

Key figures of PHARMACIE LOUDIERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LOUDIERE?

What happened at PHARMACIE LOUDIERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2026 New annual accounts for financial year 2025: profit of € 22,797 (▼ 3% vs 2024). filed late Source: NBB ↗
Jul 22, 2013 New establishment in Namur. KBO
Jul 17, 2013 Start of the company according to the CBE. KBO
2013 ARTUS LOUDIERE became a director. NBB

In short

From € 15,879 profit in 2022 to € 22,797 profit in 2025.

Paid € 41,948 in corporate taxes since 2022.

Best year ever: 2024, with € 23,483 profit.

Paid out € 39,842 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE LOUDIERE? We notify you, reason included.

Follow PHARMACIE LOUDIERE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit